GEO Accession viewer

GSM4612392	SAM24358700 Patient25 N F Etrolizumab Week14 Colon Active 1.0852216134374 GNE
GSM4612393	SAM24358701 Patient181 N F Etrolizumab Week14 Colon Active 1.11752861552487 GNE
GSM4612394	SAM24358702 Patient182 N M Etrolizumab Week14 Ileum Inactive 1.43134273554218 GNE
GSM4612395	SAM24358703 Patient149 N M Placebo Week14 Ileum Inactive 1.07126447794775 GNE
GSM4612396	SAM24358705 Patient94 Y F Etrolizumab Week14 Ileum Active 1.43677136771117 GNE
GSM4612397	SAM24358706 Patient130 Y F Placebo Week14 Colon Active 1.64608258909253 GNE
GSM4612398	SAM24359473 Patient209 Y M Etrolizumab Week14 Ileum Active 1.14682764423728 GNE
GSM4612399	SAM24358708 Patient175 N M Placebo Week14 Colon Inactive 0.862380081072457 GNE
GSM4612400	SAM24358709 Patient97 Y F Etrolizumab Week14 Ileum Active 0.997411359692174 GNE
GSM4612401	SAM24358710 Patient97 Y F Etrolizumab Screen Ileum Active 1.28807686768066 GNE
GSM4612402	SAM24358711 Patient149 N M Placebo Screen Ileum Inactive 1.44730128841206 GNE
GSM4612403	SAM24358712 Patient16 Y F Etrolizumab Screen Colon Active 1.24093199396609 GNE
GSM4612404	SAM24358713 Patient229 N F Placebo Screen Colon Active 1.00515069183882 GNE
GSM4612405	SAM24358714 Patient204 N M Etrolizumab Screen NA NA 1.29849495737973 GNE
GSM4612406	SAM24358715 Patient23 Y F Etrolizumab Screen Ileum Active 1.51529278552564 GNE
GSM4612407	SAM24358716 Patient175 N M Placebo Screen Colon Inactive 0.882640374381935 GNE
GSM4612408	SAM24358717 Patient155 N F Etrolizumab Screen Ileum Active 1.37553242956758 GNE
GSM4612409	SAM24358718 Patient237 Y F Etrolizumab Screen Ileum Inactive 1.1565538105919 GNE
GSM4612410	SAM24358719 Patient245 Y M Placebo Screen Colon Active 1.34632871642265 GNE
GSM4612411	SAM24358720 Patient130 Y F Placebo Screen NA NA 0.207107331729449 GNE
GSM4612412	SAM24358721 Patient217 Y M Etrolizumab Screen Colon Active 1.83989648497145 GNE
GSM4612413	SAM24358722 Patient181 N F Etrolizumab Screen Colon Active 1.09241709431078 GNE
GSM4612414	SAM24358723 Patient218 Y F Etrolizumab Screen Ileum Active 1.37423174454998 GNE
GSM4612415	SAM24358724 Patient55 Y F Etrolizumab Screen Colon Active 1.01194203213715 GNE
GSM4612416	SAM24358726 Patient101 Y M Etrolizumab Screen Ileum Active 1.51720999330845 GNE
GSM4612417	SAM24358727 Patient39 N F Etrolizumab Screen Ileum Active 0.428534465969921 GNE
GSM4612418	SAM24358728 Patient250 Y M Etrolizumab Screen Colon Active 1.42198824549324 GNE
GSM4612419	SAM24358730 Patient182 N M Etrolizumab Screen Ileum Inactive 1.01038809560226 GNE
GSM4612420	SAM24358732 Patient53 N F Placebo Screen Ileum Active 1.09575217982229 GNE
GSM4612421	SAM24358734 Patient100 Y M Etrolizumab Screen Ileum Active 1.21246241077586 GNE
GSM4612422	SAM24358735 Patient25 N F Etrolizumab Screen Colon Active 1.4875461389804 GNE
GSM4612423	SAM24358736 Patient94 Y F Etrolizumab Screen Ileum Active 1.2171113676937 GNE
GSM4612424	SAM24359475 Patient209 Y M Etrolizumab Screen Ileum Active 1.25086336281175 GNE
GSM4612425	SAM24358737 Patient91 Y M Etrolizumab Screen Colon Active 1.52447225002971 GNE
GSM4612426	SAM24358738 Patient11 N M Etrolizumab Screen Colon Active 0.891510476634029 GNE
GSM4612427	SAM24358740 Patient191 Y F Placebo Screen Ileum Active 1.32043271519625 GNE
GSM4612428	SAM24358741 Patient159 Y M Placebo Screen Colon Active 1.33367183913073 GNE
GSM4612429	SAM24358742 Patient201 Y M Etrolizumab Screen Ileum Active 1.59389706982623 GNE
GSM4612430	SAM24358744 Patient11 N M Etrolizumab Week14 NA NA 1.318964258843 GNE
GSM4612431	SAM24358745 Patient91 Y M Etrolizumab Week14 Colon Active 1.2275752987296 GNE
GSM4612432	SAM24358746 Patient191 Y F Placebo Week14 Ileum Active 1.10320239642938 GNE
GSM4612433	SAM24358747 Patient156 N M Etrolizumab Screen Colon Active 1.2504468014813 GNE
GSM4612434	SAM24358748 Patient114 Y F Etrolizumab Week14 Colon Active 0.520506198814762 GNE
GSM4612435	SAM24358749 Patient42 Y M Etrolizumab Week14 Colon Active 1.34307919912855 GNE
GSM4612436	SAM24358750 Patient131 N M Placebo Week14 Ileum Inactive 1.96802007161464 GNE
GSM4612437	SAM24358751 Patient69 Y F Etrolizumab Week14 Colon Inactive 1.46849411896776 GNE
GSM4612438	SAM24358752 Patient64 N M Etrolizumab Screen Colon Active 1.56491414695079 GNE
GSM4612439	SAM24358753 Patient132 Y M Etrolizumab Screen Ileum Active 1.23821116284531 GNE
GSM4612440	SAM24358754 Patient231 Y F Placebo Screen Ileum Inactive 1.40657059380287 GNE
GSM4612441	SAM24358755 Patient132 Y M Etrolizumab Week14 Colon Active 1.18080919196752 GNE
GSM4612442	SAM24358757 Patient240 Y F Etrolizumab Screen Ileum Active 1.40608883782343 GNE
GSM4612443	SAM24358758 Patient15 Y F Etrolizumab Week14 Ileum Inactive 0.266735918363797 GNE
GSM4612444	SAM24358759 Patient202 N F Etrolizumab Screen Ileum Active 1.3317042920343 GNE
GSM4612445	SAM24358760 Patient114 Y F Etrolizumab Screen Colon Active 1.65074374247202 GNE
GSM4612446	SAM24358761 Patient168 Y M Etrolizumab Screen Colon Active 1.59035690565814 GNE
GSM4612447	SAM24358762 Patient33 Y F Etrolizumab Screen Colon Active 1.47360660302414 GNE
GSM4612448	SAM24358763 Patient34 N M Placebo Screen Ileum Active 1.67178806231455 GNE
GSM4612449	SAM24358764 Patient112 Y F Etrolizumab Screen Ileum Active 1.79779032615631 GNE
GSM4612450	SAM24358765 Patient167 Y M Etrolizumab Screen Colon Active 1.7096936823572 GNE
GSM4612451	SAM24358766 Patient42 Y M Etrolizumab Screen Colon Active 1.18625906176042 GNE
GSM4612452	SAM24358767 Patient15 Y F Etrolizumab Screen Colon Active 2.15999884496987 GNE
GSM4612453	SAM24358768 Patient131 N M Placebo Screen Colon Active 2.10463303065343 GNE
GSM4612454	SAM24358769 Patient69 Y F Etrolizumab Screen Ileum Active 0.959320868356826 GNE
GSM4612455	SAM24358770 Patient50 Y F Etrolizumab Screen Ileum Active 0.14508990648393 GNE
GSM4612456	SAM24358771 Patient128 Y M Etrolizumab Week14 Ileum Active 1.69198192546614 GNE
GSM4612457	SAM24358772 Patient183 Y F Etrolizumab Week14 Ileum Active 1.41927277905051 GNE
GSM4612458	SAM24358774 Patient22 Y M Placebo Week14 Colon Active 1.46994155572711 GNE
GSM4612459	SAM24358775 Patient244 Y F Etrolizumab Week14 Ileum Active 1.06284797684247 GNE
GSM4612460	SAM24358776 Patient78 N M Etrolizumab Week14 Ileum Inactive 1.29344433990829 GNE
GSM4612461	SAM24358777 Patient220 N M Etrolizumab Week14 Colon Active 1.09651970171937 GNE
GSM4612462	SAM24358778 Patient56 Y M Etrolizumab Week14 Colon Active 1.1073892515788 GNE
GSM4612463	SAM24358779 Patient230 Y F Etrolizumab Week14 Colon Active 1.37601246905443 GNE
GSM4612464	SAM24358780 Patient221 Y F Etrolizumab Week14 Colon Active 0.982450774774243 GNE
GSM4612465	SAM24358781 Patient29 Y M Etrolizumab Week14 Colon Inactive 1.03688891621581 GNE
GSM4612466	SAM24358783 Patient75 Y F Etrolizumab Screen Colon Active 1.72918326371658 GNE
GSM4612467	SAM24358784 Patient176 Y F Placebo Screen Ileum Active 1.58874763543892 GNE
GSM4612468	SAM24358785 Patient29 Y M Etrolizumab Screen Colon Inactive 1.102474362338 GNE
GSM4612469	SAM24358786 Patient120 N F Placebo Screen Colon Active 1.14241894501942 GNE
GSM4612470	SAM24358787 Patient78 N M Etrolizumab Screen Ileum Inactive 1.07595177049108 GNE
GSM4612471	SAM24358788 Patient183 Y F Etrolizumab Screen Ileum Active 1.21415577864524 GNE
GSM4612472	SAM24358789 Patient128 Y M Etrolizumab Screen Ileum Active 1.09553142488326 GNE
GSM4612473	SAM24358790 Patient109 N F Etrolizumab Screen Ileum Inactive 0.804275932175204 GNE
GSM4612474	SAM24358791 Patient162 N M Etrolizumab Screen Ileum Inactive 1.10077658450083 GNE
GSM4612475	SAM24358792 Patient18 N M Etrolizumab Screen Ileum Active 1.3606914289133 GNE
GSM4612476	SAM24358793 Patient220 N M Etrolizumab Screen Ileum Inactive 1.80070049258098 GNE
GSM4612477	SAM24358794 Patient207 Y F Etrolizumab Screen Ileum Active 0.632472751375342 GNE
GSM4612478	SAM24358795 Patient221 Y F Etrolizumab Screen Colon Active 1.42009699767984 GNE
GSM4612479	SAM24358796 Patient56 Y M Etrolizumab Screen Colon Active 1.27806879177466 GNE
GSM4612480	SAM24358797 Patient95 N F Etrolizumab Screen Ileum Active 1.00616209709079 GNE
GSM4612481	SAM24358798 Patient244 Y F Etrolizumab Screen Ileum Active 1.09189353640894 GNE
GSM4612482	SAM24358799 Patient251 Y M Etrolizumab Screen Ileum Active 1.24681439227554 GNE
GSM4612483	SAM24358800 Patient72 Y F Etrolizumab Screen Colon Active 1.14645182451815 GNE
GSM4612484	SAM24358801 Patient253 Y M Placebo Screen Colon Active 1.81626833127885 GNE
GSM4612485	SAM24358802 Patient171 Y F Etrolizumab Screen NA NA 0.902213730726194 GNE
GSM4612486	SAM24358805 Patient129 Y M Etrolizumab Screen Colon Active 1.41710835659413 GNE
GSM4612487	SAM24358806 Patient160 N F Placebo Screen Colon Active 2.81191374694972 GNE
GSM4612488	SAM24358808 Patient8 N M Etrolizumab Screen Colon Active 1.41751174364739 GNE
GSM4612489	SAM24358809 Patient121 Y F Placebo Screen Colon Active 1.6460691519858 GNE
GSM4612490	SAM24358811 Patient7 N F Etrolizumab Week14 NA NA 1.10490895678645 GNE
GSM4612491	SAM24358813 Patient1 Y M Etrolizumab Week14 Ileum Active 0.995455522467749 GNE
GSM4612492	SAM24358815 Patient160 N F Placebo Week14 Colon Active 1.56044768447512 GNE
GSM4612493	SAM24358816 Patient57 Y F Etrolizumab Week14 Ileum Active 0.55009735382859 GNE
GSM4612494	SAM24358817 Patient185 N F Etrolizumab Week14 Colon Active 1.07094145565268 GNE
GSM4612495	SAM24358818 Patient118 Y M Etrolizumab Screen Colon Inactive 1.01166769408775 GNE
GSM4612496	SAM24358819 Patient172 N F Etrolizumab Screen Ileum Active 1.89151271173826 GNE
GSM4612497	SAM24358820 Patient186 N F Etrolizumab Week14 Colon Inactive 1.29508829327198 GNE
GSM4612498	SAM24358821 Patient105 Y F Etrolizumab Week14 Colon Active 0.952077474869441 GNE
GSM4612499	SAM24358823 Patient119 Y F Placebo Screen Ileum Inactive 1.2283698159254 GNE
GSM4612500	SAM24358824 Patient80 Y M Etrolizumab Screen Ileum Active 1.1987553984833 GNE
GSM4612501	SAM24358825 Patient87 Y M Etrolizumab Screen Colon Active 1.7814727703493 GNE
GSM4612502	SAM24358826 Patient31 N M Placebo Screen Ileum Active 1.33588001662256 GNE
GSM4612503	SAM24358827 Patient179 Y F Placebo Screen Colon Active 0.891062618509088 GNE
GSM4612504	SAM24358829 Patient158 N F Placebo Screen Ileum Active 1.45328815457731 GNE
GSM4612505	SAM24358830 Patient239 N M Etrolizumab Screen Ileum Active 0.560036126077686 GNE
GSM4612506	SAM24358831 Patient117 Y M Etrolizumab Week14 Colon Inactive 1.28275037039521 GNE
GSM4612507	SAM24358833 Patient80 Y M Etrolizumab Week14 Ileum Active 1.08770220650441 GNE
GSM4612508	SAM24358834 Patient239 N M Etrolizumab Week14 Ileum Active 0.937363660022008 GNE
GSM4612509	SAM24358835 Patient158 N F Placebo Week14 Ileum Active 1.26759627504365 GNE
GSM4612510	SAM24358836 Patient119 Y F Placebo Week14 Colon Active 1.48472017820998 GNE
GSM4612511	SAM24358837 Patient43 Y F Placebo Screen NA NA 1.27632623447686 GNE
GSM4612512	SAM24358838 Patient186 N F Etrolizumab Screen Ileum Active 1.83683086674201 GNE
GSM4612513	SAM24358839 Patient105 Y F Etrolizumab Screen Colon Active 2.06154765543013 GNE
GSM4612514	SAM24358840 Patient171 Y F Etrolizumab Week14 Colon Active 1.37010263214681 GNE
GSM4612515	SAM24358841 Patient206 N F Placebo Week14 Ileum Active 0.957347297828332 GNE
GSM4612516	SAM24358842 Patient35 Y M Etrolizumab Week14 Ileum Active 1.71606572533799 GNE
GSM4612517	SAM24358844 Patient127 Y F Etrolizumab Screen Colon Active 0.981178830101958 GNE
GSM4612518	SAM24358845 Patient35 Y M Etrolizumab Screen Ileum Active 1.60993030252513 GNE
GSM4612519	SAM24358846 Patient7 N F Etrolizumab Screen Ileum Active 0.798657343181959 GNE
GSM4612520	SAM24358847 Patient57 Y F Etrolizumab Screen Ileum Active 1.61019803284863 GNE
GSM4612521	SAM24358848 Patient10 Y M Etrolizumab Screen Ileum Active 0.147376745476419 GNE
GSM4612522	SAM24358849 Patient20 N M Etrolizumab Screen Colon Active 1.64567192365636 GNE
GSM4612523	SAM24358850 Patient180 N F Placebo Screen Ileum Active 1.25728034498004 GNE
GSM4612524	SAM24358854 Patient206 N F Placebo Screen Ileum Active 0.252133994682536 GNE
GSM4612525	SAM24358855 Patient173 Y F Etrolizumab Screen Colon Active 4.69782598505944 GNE
GSM4612526	SAM24358860 Patient242 N M Etrolizumab Week14 Colon Active 0.710685203694578 GNE
GSM4612527	SAM24358899 Patient138 Y F Etrolizumab Screen Ileum Active 0.546876219765805 GNE
GSM4612528	SAM24358901 Patient32 Y F Etrolizumab Week14 Colon Inactive 0.200172081126897 GNE
GSM4612529	SAM24358922 Patient143 Y F Etrolizumab Week14 Colon Active 0.469022973478368 GNE
GSM4612530	SAM24358925 Patient157 N F Placebo Screen Colon Active 0.622391528836999 GNE
GSM4612531	SAM24358943 Patient147 Y M Etrolizumab Week14 Ileum Active 0.713970069666852 GNE
GSM4612532	SAM24358954 Patient13 Y M Placebo Screen Colon Active 0.714025329924482 GNE
GSM4612533	SAM24358957 Patient140 N M Etrolizumab Screen Colon Active 0.919037702795766 GNE
GSM4612534	SAM24358963 Patient116 N M Etrolizumab Screen Ileum Inactive 1.21952003848992 GNE
GSM4612535	SAM24358972 Patient49 Y F Etrolizumab Screen Colon Active 0.921670240852045 GNE
GSM4612536	SAM24358975 Patient219 Y M Etrolizumab Screen Ileum Active 0.843013689303291 GNE
GSM4612537	SAM24358986 Patient234 N F Etrolizumab Week14 Colon Active 0.775903281765532 GNE
GSM4612538	SAM24358994 Patient153 Y M Etrolizumab Week14 Ileum Active 1.03181140817958 GNE
GSM4612539	SAM24359005 Patient203 Y M Placebo Screen Ileum Active 1.34036273665687 GNE
GSM4612540	SAM24359012 Patient169 Y F Etrolizumab Screen Colon Active 1.56999552253821 GNE
GSM4612541	SAM24359014 Patient195 Y M Etrolizumab Screen Ileum Inactive 0.930973338816562 GNE
GSM4612542	SAM24359035 Patient93 N F Placebo Week14 NA NA 0.700390171170594 GNE
GSM4612543	SAM24359036 Patient98 Y F Etrolizumab Week14 NA NA 0.656637242016896 GNE
GSM4612544	SAM24359039 Patient174 N M Etrolizumab Screen NA NA 0.546397597766511 GNE
GSM4612545	SAM24359041 Patient226 N F Placebo Screen Ileum Active 0.887321943476807 GNE
GSM4612546	SAM24359043 Patient70 Y M Etrolizumab Screen Colon Active 0.600439156410614 GNE
GSM4612547	SAM24359045 Patient85 Y F Etrolizumab Screen Ileum Active 1.0221655746593 GNE
GSM4612548	SAM24359047 Patient90 Y F Etrolizumab Screen Ileum Active 0.902909857669553 GNE
GSM4612549	SAM24359054 Patient238 Y M Etrolizumab Screen Ileum Active 0.939832437536524 GNE
GSM4612550	SAM24359055 Patient148 Y M Placebo Screen Ileum Active 0.863001052996154 GNE
GSM4612551	SAM24359057 Patient14 N M Etrolizumab Screen Colon Active 0.616717314345941 GNE
GSM4612552	SAM24359058 Patient68 Y M Etrolizumab Screen Ileum Inactive 0.559697287740751 GNE
GSM4612553	SAM24359059 Patient12 N F Etrolizumab Screen Colon Active 1.08523012049247 GNE
GSM4612554	SAM24359062 Patient137 N M Etrolizumab Screen Colon Active 0.998164425577036 GNE
GSM4612555	SAM24359065 Patient151 Y F Placebo Screen NA NA 0.107386227430314 GNE
GSM4612556	SAM24359067 Patient71 Y F Etrolizumab Screen Ileum Active 0.259445859478652 GNE
GSM4612557	SAM24359068 Patient113 Y F Etrolizumab Week14 Colon Inactive 0.999246912569148 GNE
GSM4612558	SAM24359069 Patient137 N M Etrolizumab Week14 Ileum Inactive 0.633923042899757 GNE
GSM4612559	SAM24359071 Patient216 Y F Placebo Week14 Ileum Active 0.838011222907924 GNE
GSM4612560	SAM24359075 Patient5 Y M Placebo Screen Ileum Active 0.163178394592882 GNE
GSM4612561	SAM24359076 Patient190 N M Etrolizumab Screen Ileum Active 0.408883290668201 GNE
GSM4612562	SAM24359094 Patient14 N M Etrolizumab Week14 Ileum Active 1.28949142760047 GNE
GSM4612563	SAM24359105 Patient104 N M Etrolizumab Week14 Ileum Active 0.115880288490518 GNE
GSM4612564	SAM24358856 Patient24 Y M Etrolizumab Week14 Colon Active 0.837046578269241 GNE
GSM4612565	SAM24358857 Patient19 Y F Etrolizumab Week14 Ileum Active 1.31005212551282 GNE
GSM4612566	SAM24358858 Patient198 N F Placebo Week14 Ileum Active 0.88573787619345 GNE
GSM4612567	SAM24358862 Patient44 N M Etrolizumab Week14 Ileum Active 0.783686857846115 GNE
GSM4612568	SAM24358863 Patient246 Y M Etrolizumab Week14 Ileum Active 0.419127385628177 GNE
GSM4612569	SAM24358864 Patient3 Y F Etrolizumab Week14 Ileum Active 1.12367660466996 GNE
GSM4612570	SAM24358865 Patient88 N F Etrolizumab Week14 Colon Active 1.05484599779268 GNE
GSM4612571	SAM24358866 Patient65 Y M Placebo Week14 Ileum Active 0.822664307308962 GNE
GSM4612572	SAM24358867 Patient213 Y F Etrolizumab Week14 Ileum Active 0.954990902665667 GNE
GSM4612573	SAM24358869 Patient146 N M Placebo Week14 Ileum Active 0.85959564650208 GNE
GSM4612574	SAM24358870 Patient122 Y M Etrolizumab Screen Ileum Active 0.874514058415886 GNE
GSM4612575	SAM24358871 Patient40 N M Etrolizumab Screen Ileum Active 0.895218932042548 GNE
GSM4612576	SAM24358872 Patient3 Y F Etrolizumab Screen Colon Active 1.46287650938188 GNE
GSM4612577	SAM24358873 Patient88 N F Etrolizumab Screen Ileum Active 0.704498285422863 GNE
GSM4612578	SAM24358874 Patient125 Y M Etrolizumab Screen NA NA 0.507068020496903 GNE
GSM4612579	SAM24358876 Patient24 Y M Etrolizumab Screen Colon Active 0.449390838550654 GNE
GSM4612580	SAM24358877 Patient198 N F Placebo Screen Ileum Active 0.521440132942372 GNE
GSM4612581	SAM24358879 Patient115 N M Etrolizumab Screen Ileum Active 0.772609367867899 GNE
GSM4612582	SAM24358884 Patient41 N M Etrolizumab Screen Ileum Active 0.39876141846235 GNE
GSM4612583	SAM24358945 Patient243 N F Etrolizumab Week14 NA NA 0.0215080599738704 GNE
GSM4612584	SAM24358950 Patient116 N M Etrolizumab Week14 Ileum Inactive 0.440977000634017 GNE
GSM4612585	SAM24358976 Patient59 N F Etrolizumab Screen Colon Active 0.459441444844913 GNE
GSM4612586	SAM24358980 Patient21 Y F Etrolizumab Screen Ileum Inactive 0.824379066340912 GNE
GSM4612587	SAM24358982 Patient62 Y M Etrolizumab Screen Ileum Active 0.680614152961684 GNE
GSM4612588	SAM24358989 Patient110 N M Etrolizumab Week14 Ileum Active 0.621921174731079 GNE
GSM4612589	SAM24358991 Patient45 Y F Etrolizumab Week14 Ileum Active 0.55440681523115 GNE
GSM4612590	SAM24358993 Patient188 N M Placebo Week14 Colon Active 0.570048699560185 GNE
GSM4612591	SAM24358995 Patient164 Y M Etrolizumab Screen Colon Active 0.840745473932825 GNE
GSM4612592	SAM24358996 Patient107 Y F Etrolizumab Screen Colon Active 0.732452348586439 GNE
GSM4612593	SAM24358997 Patient110 N M Etrolizumab Screen Ileum Active 0.673544433356474 GNE
GSM4612594	SAM24359004 Patient139 N F Etrolizumab Week14 Colon Active 0.520719352453665 GNE
GSM4612595	SAM24359007 Patient248 Y M Etrolizumab Week14 Ileum Active 0.522168655282719 GNE
GSM4612596	SAM24359008 Patient197 Y F Etrolizumab Screen Colon Active 0.90468489830581 GNE
GSM4612597	SAM24359010 Patient134 Y F Placebo Screen Ileum NA 1.2759919019223 GNE
GSM4612598	SAM24359053 Patient178 N M Etrolizumab Screen Ileum Active 0.436817280144217 GNE
GSM4612599	SAM24359077 Patient103 Y F Etrolizumab Screen Colon Active 0.462848161896727 GNE
GSM4612600	SAM24359085 Patient144 Y F Etrolizumab Screen NA NA 0.468141685000887 GNE
GSM4612601	SAM24359086 Patient235 Y F Placebo Screen Colon Active 0.481967793611142 GNE
GSM4612602	SAM24359092 Patient37 N F Etrolizumab Screen Ileum Active 0.542749117105395 GNE
GSM4612603	SAM24359101 Patient249 Y M Etrolizumab Screen Colon Active 0.521276707082835 GNE
GSM4612604	SAM24358852 Patient185 N F Etrolizumab Screen Ileum Inactive 1.7011028611082 GNE
GSM4612605	SAM24358853 Patient1 Y M Etrolizumab Screen NA NA 0.903326893806885 GNE
GSM4612606	SAM24358940 Patient145 Y F Etrolizumab Screen Colon Active 3.10956682882786 GNE
GSM4612607	SAM24358941 Patient163 N F Etrolizumab Week14 Ileum Active 1.01799213515747 GNE
GSM4612608	SAM24358942 Patient165 N F Etrolizumab Week14 Ileum Active 0.539482783734792 GNE
GSM4612609	SAM24358946 Patient133 Y M Etrolizumab Week14 Colon Active 0.61568492932463 GNE
GSM4612610	SAM24358948 Patient212 N M Etrolizumab Week14 Ileum Active 0.800167812464321 GNE
GSM4612611	SAM24358949 Patient219 Y M Etrolizumab Week14 Ileum Active 0.779581215679047 GNE
GSM4612612	SAM24358952 Patient27 Y F Etrolizumab Screen Ileum Active 0.63839571913048 GNE
GSM4612613	SAM24358956 Patient212 N M Etrolizumab Screen NA NA 0.537487462021725 GNE
GSM4612614	SAM24358959 Patient77 N M Etrolizumab Screen Ileum Active 0.575749570021822 GNE
GSM4612615	SAM24358960 Patient165 N F Etrolizumab Screen Ileum Active 1.00596448161558 GNE
GSM4612616	SAM24358962 Patient4 Y M Placebo Screen Colon Active 0.607763115388128 GNE
GSM4612617	SAM24358968 Patient163 N F Etrolizumab Screen Ileum Active 0.649727582222595 GNE
GSM4612618	SAM24358970 Patient147 Y M Etrolizumab Screen Ileum Active 0.839764829044132 GNE
GSM4612619	SAM24358979 Patient38 N F Etrolizumab Screen Ileum Active 0.768932813439224 GNE
GSM4612620	SAM24358983 Patient223 Y F Placebo Screen Ileum Active 0.642624021738392 GNE
GSM4612621	SAM24358990 Patient107 Y F Etrolizumab Week14 Colon Active 0.584782208685013 GNE
GSM4612622	SAM24359000 Patient164 Y M Etrolizumab Week14 Colon Active 0.567581499283838 GNE
GSM4612623	SAM24359002 Patient188 N M Placebo Screen Colon Active 0.712207022649384 GNE
GSM4612624	SAM24359011 Patient248 Y M Etrolizumab Screen Colon Active 0.650620849001612 GNE
GSM4612625	SAM24359022 Patient228 N F Etrolizumab Week14 Colon Active 0.368310942072465 GNE
GSM4612626	SAM24359023 Patient241 Y M Etrolizumab Week14 Ileum Active 0.718232323512686 GNE
GSM4612627	SAM24359024 Patient123 N M Placebo Week14 Ileum Active 0.372138000921967 GNE
GSM4612628	SAM24359025 Patient178 N M Etrolizumab Week14 Colon Active 0.674191751986521 GNE
GSM4612629	SAM24359027 Patient68 Y M Etrolizumab Week14 Ileum Inactive 0.471838856255114 GNE
GSM4612630	SAM24359028 Patient177 Y F Etrolizumab Week14 Ileum Active 0.51420102206451 GNE
GSM4612631	SAM24359030 Patient47 Y M Placebo Week14 Colon Active 0.402852382353691 GNE
GSM4612632	SAM24359031 Patient148 Y M Placebo Week14 Colon Active 0.401187574973767 GNE
GSM4612633	SAM24359032 Patient199 N F Etrolizumab Week14 Ileum Active 0.408572234595874 GNE
GSM4612634	SAM24359034 Patient6 N M Etrolizumab Week14 Colon Active 0.369355433198945 GNE
GSM4612635	SAM24359037 Patient6 N M Etrolizumab Screen Colon Active 0.514036348423806 GNE
GSM4612636	SAM24359040 Patient26 Y F Etrolizumab Screen NA NA 0.549584721111796 GNE
GSM4612637	SAM24359048 Patient47 Y M Placebo Screen Ileum NA 0.527131525628113 GNE
GSM4612638	SAM24359050 Patient93 N F Placebo Screen NA NA 0.413979950056635 GNE
GSM4612639	SAM24359051 Patient177 Y F Etrolizumab Screen Ileum Active 0.392603965684564 GNE
GSM4612640	SAM24359056 Patient102 Y F Etrolizumab Screen Ileum Inactive 0.519889558161615 GNE
GSM4612641	SAM24359060 Patient135 Y F Etrolizumab Week14 Ileum Active 0.695200181455644 GNE
GSM4612642	SAM24359072 Patient71 Y F Etrolizumab Week14 Colon Inactive 0.450736180193313 GNE
GSM4612643	SAM24359079 Patient150 N F Etrolizumab Week14 Colon Active 0.403677317009702 GNE
GSM4612644	SAM24359080 Patient103 Y F Etrolizumab Week14 Ileum Inactive 0.557124083450933 GNE
GSM4612645	SAM24359082 Patient66 Y M Placebo Screen Colon Active 0.562531991083448 GNE
GSM4612646	SAM24359083 Patient192 Y F Etrolizumab Screen Colon Active 0.423906539371962 GNE
GSM4612647	SAM24359087 Patient89 N M Etrolizumab Week14 Ileum Active 0.452482406134555 GNE
GSM4612648	SAM24359088 Patient144 Y F Etrolizumab Week14 Colon Active 0.677648410796768 GNE
GSM4612649	SAM24359089 Patient192 Y F Etrolizumab Week14 Colon Active 0.442140060737685 GNE
GSM4612650	SAM24359093 Patient58 N F Etrolizumab Week14 Colon Active 0.737283015506073 GNE
GSM4612651	SAM24359095 Patient37 N F Etrolizumab Week14 Ileum Active 0.573036454270569 GNE
GSM4612652	SAM24359096 Patient166 Y F Etrolizumab Week14 Colon Active 0.769365490671485 GNE
GSM4612653	SAM24359100 Patient111 Y M Etrolizumab Screen Ileum Active 0.556432021706481 GNE
GSM4612654	SAM24359102 Patient166 Y F Etrolizumab Screen Ileum Active 0.579198225624011 GNE
GSM4612655	SAM24359103 Patient17 Y M Etrolizumab Screen Colon Active 0.476778847213831 GNE
GSM4612656	SAM24359104 Patient79 Y F Etrolizumab Screen Ileum Inactive 0.663774407580972 GNE
GSM4612657	SAM24358984 Patient21 Y F Etrolizumab Week14 Ileum Inactive 1.17300405235483 Almac
GSM4612658	SAM24358889 Patient2 Y M Etrolizumab Screen Ileum Active 1.38690696598979 Almac
GSM4612659	SAM24358910 Patient28 Y F Etrolizumab Week14 Ileum Active 1.78531668311993 Almac
GSM4612660	SAM24358939 Patient28 Y F Etrolizumab Screen Ileum Active 1.58810014901479 Almac
GSM4612661	SAM24358882 Patient30 N M Etrolizumab Screen Ileum Active 1.66135561317039 Almac
GSM4612662	SAM24358905 Patient32 Y F Etrolizumab Screen Ileum Active 1.67069508573148 Almac
GSM4612663	SAM24358919 Patient36 N M Placebo Screen Colon Inactive 1.3440393710668 Almac
GSM4612664	SAM24358985 Patient38 N F Etrolizumab Week14 Ileum Active 1.82587169886012 Almac
GSM4612665	SAM24358881 Patient44 N M Etrolizumab Screen Ileum Active 1.96543485506124 Almac
GSM4612666	SAM24358974 Patient46 Y M Etrolizumab Screen NA NA 1.48063763253517 Almac
GSM4612667	SAM24358999 Patient48 Y M Etrolizumab Week14 Colon Active 1.44163331137064 Almac
GSM4612668	SAM24359013 Patient48 Y M Etrolizumab Screen Colon Active 1.69090059624309 Almac
GSM4612669	SAM24359044 Patient51 N M Etrolizumab Screen Ileum Active 1.62857341622343 Almac
GSM4612670	SAM24358914 Patient52 Y F Etrolizumab Screen Ileum Active 1.49118367437446 Almac
GSM4612671	SAM24358927 Patient54 Y F Placebo Screen Ileum Active 1.41459211247667 Almac
GSM4612672	SAM24359061 Patient58 N F Etrolizumab Screen Colon Active 0.963447156655618 Almac
GSM4612673	SAM24358902 Patient60 Y F Etrolizumab Week14 Ileum Active 1.13101143637218 Almac
GSM4612674	SAM24358951 Patient61 Y F Etrolizumab Week14 Ileum Active 1.3472879446523 Almac
GSM4612675	SAM24358953 Patient61 Y F Etrolizumab Screen Ileum Active 1.85476641292337 Almac
GSM4612676	SAM24358947 Patient63 Y M Etrolizumab Week14 Ileum Inactive 1.63264242435337 Almac
GSM4612677	SAM24358961 Patient63 Y M Etrolizumab Screen Ileum Inactive 1.53471252028586 Almac
GSM4612678	SAM24358810 Patient184 Y M Etrolizumab Screen Colon Inactive 1.40667857077306 Almac
GSM4612679	SAM24358921 Patient187 Y F Etrolizumab Week14 Ileum Active 1.45553102598387 Almac
GSM4612680	SAM24358933 Patient187 Y F Etrolizumab Screen Ileum Active 1.46563241530222 Almac
GSM4612681	SAM24358903 Patient189 N F Etrolizumab Screen Colon Active 1.76596516836928 Almac
GSM4612682	SAM24359070 Patient190 N M Etrolizumab Week14 Colon Active 1.85834185693455 Almac
GSM4612683	SAM24358918 Patient193 Y F Placebo Week14 Colon Active 1.43032101989769 Almac
GSM4612684	SAM24358913 Patient193 Y F Placebo Screen Colon Active 1.21485273615673 Almac
GSM4612685	SAM24358988 Patient194 Y F Etrolizumab Week14 Ileum Active 1.86035876962982 Almac
GSM4612686	SAM24359020 Patient195 Y M Etrolizumab Week14 Colon Active 1.68844583976897 Almac
GSM4612687	SAM24359099 Patient196 N M Etrolizumab Screen Colon Active 1.44850028195782 Almac
GSM4612688	SAM24359001 Patient197 Y F Etrolizumab Week14 Ileum Active 1.95320644156882 Almac
GSM4612689	SAM24359046 Patient199 N F Etrolizumab Screen Colon Active 1.19465435237613 Almac
GSM4612690	SAM24358704 Patient200 Y M Placebo Week14 Colon Active 1.33834601809613 Almac
GSM4612691	SAM24358756 Patient202 N F Etrolizumab Week14 Ileum Active 1.66832736162325 Almac
GSM4612692	SAM24358878 Patient65 Y M Placebo Screen Ileum Active 1.24074715413724 Almac
GSM4612693	SAM24358883 Patient205 Y M Etrolizumab Screen Colon Active 1.58182701054765 Almac
GSM4612694	SAM24358896 Patient208 Y M Etrolizumab Screen Ileum Active 1.33202884175395 Almac
GSM4612695	SAM24359474 Patient210 Y M Etrolizumab Screen Ileum Active 1.60866939347923 Almac
GSM4612696	SAM24358930 Patient211 N M Etrolizumab Week14 NA NA 1.18536384960078 Almac
GSM4612697	SAM24358926 Patient211 N M Etrolizumab Screen Colon Active 1.46642067497214 Almac
GSM4612698	SAM24358885 Patient213 Y F Etrolizumab Screen Ileum Active 1.74480541926769 Almac
GSM4612699	SAM24358944 Patient214 Y F Etrolizumab Week14 Ileum Active 1.78533896506747 Almac
GSM4612700	SAM24358969 Patient214 Y F Etrolizumab Screen Ileum Active 1.43112778220996 Almac
GSM4612701	SAM24358900 Patient215 N F Etrolizumab Screen Colon Active 1.08696917088876 Almac
GSM4612702	SAM24358868 Patient222 Y M Etrolizumab Week14 Colon Active 0.831263032701823 Almac
GSM4612703	SAM24358888 Patient222 Y M Etrolizumab Screen Ileum Inactive 1.03326572585281 Almac
GSM4612704	SAM24358897 Patient224 Y F Etrolizumab Week14 Ileum Active 1.09736702111602 Almac
GSM4612705	SAM24358895 Patient224 Y F Etrolizumab Screen Ileum Active 1.19024015771199 Almac
GSM4612706	SAM24358966 Patient225 Y F Etrolizumab Screen Ileum Active 1.04497349118583 Almac
GSM4612707	SAM24358890 Patient227 Y M Placebo Screen Colon Active 1.25945681592073 Almac
GSM4612708	SAM24358978 Patient232 Y M Placebo Screen Colon Active 1.40443588393732 Almac
GSM4612709	SAM24358931 Patient233 Y F Etrolizumab Week14 Colon Active 1.31744839919364 Almac
GSM4612710	SAM24358928 Patient233 Y F Etrolizumab Screen Ileum Active 1.36658381483774 Almac
GSM4612711	SAM24358981 Patient234 N F Etrolizumab Screen Colon Active 1.97394113389663 Almac
GSM4612712	SAM24359090 Patient235 Y F Placebo Week14 Ileum Active 1.29368702967867 Almac
GSM4612713	SAM24359017 Patient236 N M Etrolizumab Week14 Ileum Inactive 1.73433980759175 Almac
GSM4612714	SAM24358967 Patient236 N M Etrolizumab Screen Ileum Inactive 2.19256125558248 Almac
GSM4612715	SAM24359033 Patient238 Y M Etrolizumab Week14 Colon Active 1.75962305441655 Almac
GSM4612716	SAM24358958 Patient67 Y F Etrolizumab Screen Colon Active 1.12508277534471 Almac
GSM4612717	SAM24358937 Patient247 Y F Placebo Week14 Ileum Active 1.25910009395661 Almac
GSM4612718	SAM24358909 Patient247 Y F Placebo Screen Ileum Active 1.51496596621681 Almac
GSM4612719	SAM24359471 Patient252 Y M Etrolizumab Screen Ileum Active 1.70698451252995 Almac
GSM4612720	SAM24359063 Patient73 Y M Etrolizumab Screen NA NA 1.64486154544362 Almac
GSM4612721	SAM24358894 Patient74 N F Etrolizumab Screen Colon Active 1.37569143895328 Almac
GSM4612722	SAM24358924 Patient76 N M Etrolizumab Screen Colon Inactive 1.48467533927858 Almac
GSM4612723	SAM24359106 Patient79 Y F Etrolizumab Week14 Colon Active 1.13360986476642 Almac
GSM4612724	SAM24359018 Patient81 N M Etrolizumab Week14 Colon Active 1.45989573566254 Almac
GSM4612725	SAM24358887 Patient82 Y F Etrolizumab Screen Ileum Inactive 1.6188344652324 Almac
GSM4612726	SAM24359021 Patient83 Y F Etrolizumab Week14 Ileum Active 1.73848483099913 Almac
GSM4612727	SAM24358971 Patient83 Y F Etrolizumab Screen Ileum Active 1.34534358957035 Almac
GSM4612728	SAM24358955 Patient84 Y F Placebo Screen Ileum Active 1.06924959924252 Almac
GSM4612729	SAM24359029 Patient85 Y F Etrolizumab Week14 Ileum Active 1.3978003036469 Almac
GSM4612730	SAM24358987 Patient86 N F Placebo Screen Ileum Active 1.35970825687319 Almac
GSM4612731	SAM24359084 Patient89 N M Etrolizumab Screen Colon Inactive 1.36830559249814 Almac
GSM4612732	SAM24358923 Patient92 N F Etrolizumab Week14 Ileum Active 1.38319166848031 Almac
GSM4612733	SAM24358932 Patient92 N F Etrolizumab Screen Colon Inactive 0.989156175912907 Almac
GSM4612734	SAM24358773 Patient95 N F Etrolizumab Week14 Ileum Active 1.30005214324376 Almac
GSM4612735	SAM24359066 Patient96 Y M Etrolizumab Screen NA NA 1.29510016370573 Almac
GSM4612736	SAM24358998 Patient99 Y M Etrolizumab Screen Ileum Active 1.54184035866109 Almac
GSM4612737	SAM24359049 Patient104 N M Etrolizumab Screen Ileum Active 1.62643177932904 Almac
GSM4612738	SAM24358907 Patient106 Y F Etrolizumab Week14 Colon Active 1.48120609004028 Almac
GSM4612739	SAM24358915 Patient106 Y F Etrolizumab Screen Colon Active 1.28118018186059 Almac
GSM4612740	SAM24359098 Patient108 Y M Etrolizumab Screen Ileum Inactive 1.60971117342137 Almac
GSM4612741	SAM24359081 Patient111 Y M Etrolizumab Week14 Colon Inactive 1.48110326104029 Almac
GSM4612742	SAM24359091 Patient113 Y F Etrolizumab Screen Ileum Active 1.70807503455487 Almac
GSM4612743	SAM24358812 Patient121 Y F Placebo Week14 Colon Active 1.83371229281879 Almac
GSM4612744	SAM24359042 Patient123 N M Placebo Screen NA NA 1.73674442921922 Almac
GSM4612745	SAM24358908 Patient9 N F Etrolizumab Screen Ileum Active 1.66476810233265 Almac
GSM4612746	SAM24358934 Patient124 Y F Placebo Screen Colon Active 1.357786153983 Almac
GSM4612747	SAM24358920 Patient126 N M Etrolizumab Week14 Ileum Inactive 0.744757884791543 Almac
GSM4612748	SAM24358912 Patient126 N M Etrolizumab Screen Ileum Inactive 1.79105173390952 Almac
GSM4612749	SAM24358814 Patient127 Y F Etrolizumab Week14 Colon Active 1.56548076851987 Almac
GSM4612750	SAM24358965 Patient133 Y M Etrolizumab Screen Colon Active 1.57550760946028 Almac
GSM4612751	SAM24359074 Patient135 Y F Etrolizumab Screen Ileum Active 1.04890929907953 Almac
GSM4612752	SAM24358906 Patient136 N M Etrolizumab Screen Colon Active 1.26367036202682 Almac
GSM4612753	SAM24358911 Patient138 Y F Etrolizumab Week14 Colon Active 1.44091624243352 Almac
GSM4612754	SAM24359003 Patient139 N F Etrolizumab Screen Colon Active 1.94798408962427 Almac
GSM4612755	SAM24358861 Patient141 N M Etrolizumab Week14 Colon Active 1.52914071371547 Almac
GSM4612756	SAM24359015 Patient142 Y F Etrolizumab Screen NA NA 1.26228482989277 Almac
GSM4612757	SAM24358938 Patient143 Y F Etrolizumab Screen Ileum Active 1.51187651243856 Almac
GSM4612758	SAM24358992 Patient145 Y F Etrolizumab Week14 Colon Active 1.69717501623991 Almac
GSM4612759	SAM24358880 Patient146 N M Placebo Screen Ileum Active 1.4343419433774 Almac
GSM4612760	SAM24359026 Patient12 N F Etrolizumab Week14 Ileum Inactive 1.68351790906819 Almac
GSM4612761	SAM24359078 Patient150 N F Etrolizumab Screen Colon Active 1.43020527475794 Almac
GSM4612762	SAM24358916 Patient152 Y F Etrolizumab Screen Colon Inactive 1.40758400268284 Almac
GSM4612763	SAM24359019 Patient153 Y M Etrolizumab Screen Ileum Active 1.51933414375919 Almac
GSM4612764	SAM24358807 Patient154 N M Placebo Screen Colon Active 1.45153418945674 Almac
GSM4612765	SAM24358973 Patient161 Y M Etrolizumab Screen Ileum Active 1.47981335142568 Almac
GSM4612766	SAM24358782 Patient162 N M Etrolizumab Week14 Ileum Inactive 1.33859515499425 Almac
GSM4612767	SAM24358904 Patient170 Y M Etrolizumab Week14 Ileum Active 1.33583405016517 Almac
GSM4612768	SAM24358822 Patient173 Y F Etrolizumab Week14 Colon Active 1.56338982857335 Almac
GSM4612769	SAM24358832 Patient179 Y F Placebo Week14 Colon Active 1.33870573015122 Almac
GSM4612770	SAM24358886 Patient19 Y F Etrolizumab Screen Ileum Active 1.79125069762535 Almac